Beranda › Neoplasma Mieloproliferatif
Uji klinis Neoplasma Mieloproliferatif yang merekrut di AS
50 studi untuk Neoplasma Mieloproliferatif merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX16 studi
- New York City, NY15 studi
- Boston, MA14 studi
- Milwaukee, WI10 studi
- Miami, FL10 studi
- Chicago, IL9 studi
- Durham, NC9 studi
- Baldwin Park, CA9 studi
- Seattle, WA9 studi
- Salt Lake City, UT8 studi
- Cleveland, OH8 studi
- Birmingham, AL8 studi
- Tampa, FL8 studi
- Columbus, OH8 studi
- Atlanta, GA8 studi
- St. Louis, MO8 studi
- Philadelphia, PA8 studi
- Portland, OR8 studi
- Baltimore, MD7 studi
- Los Angeles, CA7 studi
- Mountain View, CA7 studi
- Kansas City, MO7 studi
- Winston-Salem, NC7 studi
- Nashville, TN6 studi
- Charlotte, NC6 studi
- Irvine, CA6 studi
- Jacksonville, FL6 studi
- Ann Arbor, MI6 studi
- Phoenix, AZ6 studi
- Sacramento, CA5 studi
- Washington, DC5 studi
- Edison, NJ5 studi
- Omaha, NE5 studi
- San Francisco, CA5 studi
- Charlottesville, VA5 studi
- Rochester, MN5 studi
- Pittsburgh, PA5 studi
- Minneapolis, MN5 studi
- The Bronx, NY4 studi
- New Haven, CT4 studi
Berdasarkan negara bagian
- Alabama8 studi
- Arizona8 studi
- Arkansas4 studi
- California17 studi
- Colorado6 studi
- Connecticut5 studi
- Florida13 studi
- Georgia10 studi
- Hawaii3 studi
- Idaho4 studi
- Illinois9 studi
- Indiana4 studi
- Iowa4 studi
- Kansas6 studi
- Kentucky3 studi
- Louisiana4 studi
- Maine4 studi
- Maryland8 studi
- Massachusetts15 studi
- Michigan8 studi
- Minnesota8 studi
- Mississippi4 studi
- Missouri8 studi
- Montana3 studi
- Nebraska5 studi
- Nevada3 studi
- New Jersey5 studi
- New Mexico4 studi
- New York15 studi
- North Carolina13 studi
- Ohio11 studi
- Oklahoma5 studi
- Oregon8 studi
- Pennsylvania10 studi
- Rhode Island4 studi
- South Carolina5 studi
- Tennessee8 studi
- Texas18 studi
- Utah8 studi
- Vermont3 studi
- Virginia6 studi
- Washington9 studi
- Wisconsin10 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Menerima pesertaFase 1/2
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06303193A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07469891Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06661915MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05320198Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Menerima pesertaFase 2
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05554406Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Menerima pesertaFase 1
Usia 1 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03630991Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04282187(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT03471260Cord Blood Transplant in Adults With Blood Cancers
Menerima pesertaFase 2
Usia 21 hingga 65 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT05884333Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT06291987Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT06523556CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04493164Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Menerima peserta
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04898790Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07565220A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07008118Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07249840A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07020533Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07441694Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Menerima pesertaFase 2
6 Months – 65 Years · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06013423Evaluation of the Pathobiology of CALR-mutated MPN Cells
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06480591Allo HSCT Using RIC and PTCy for Hematological Diseases
Menerima pesertaFase 2
Hingga usia 75 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT05805605Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.